809 related articles for article (PubMed ID: 27418121)
1. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
Christensen HD; Sheta HM; Morillon MB; Hansen IM
Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
[TBL] [Abstract][Full Text] [Related]
2. Concurrent validity of provisional remission criteria for gout: a dual-energy CT study.
Dalbeth N; Frampton C; Fung M; Baumgartner S; Nicolaou S; Choi HK
Arthritis Res Ther; 2019 Jun; 21(1):150. PubMed ID: 31227018
[TBL] [Abstract][Full Text] [Related]
3. Comparison of dual-energy CT, ultrasound and surface measurement for assessing tophus dissolution during rapid urate debulking.
Modjinou DV; Krasnokutsky S; Gyftopoulos S; Pike VC; Karis E; Keenan RT; Lee K; Crittenden DB; Samuels J; Pillinger MH
Clin Rheumatol; 2017 Sep; 36(9):2101-2107. PubMed ID: 28623421
[TBL] [Abstract][Full Text] [Related]
4. Presence of monosodium urate crystal deposition by dual-energy CT in patients with gout treated with allopurinol.
Dalbeth N; Nicolaou S; Baumgartner S; Hu J; Fung M; Choi HK
Ann Rheum Dis; 2018 Mar; 77(3):364-370. PubMed ID: 29146741
[TBL] [Abstract][Full Text] [Related]
5. Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Ellmann H; Bayat S; Araujo E; Manger B; Kleyer A; Cavallaro A; Lell M; Schenker H; Simon D; Tascilar K; Baraf HSB; Schett G; Rech J
Arthritis Rheumatol; 2020 Jan; 72(1):150-156. PubMed ID: 31353871
[TBL] [Abstract][Full Text] [Related]
6. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout.
Perez-Ruiz F; Calabozo M; Pijoan JI; Herrero-Beites AM; Ruibal A
Arthritis Rheum; 2002 Aug; 47(4):356-60. PubMed ID: 12209479
[TBL] [Abstract][Full Text] [Related]
7. Dual-energy computed tomography as a diagnostic tool for gout during intercritical periods.
Breuer GS; Bogot N; Nesher G
Int J Rheum Dis; 2016 Dec; 19(12):1337-1341. PubMed ID: 27458073
[TBL] [Abstract][Full Text] [Related]
8. Lack of change in urate deposition by dual-energy computed tomography among clinically stable patients with long-standing tophaceous gout: a prospective longitudinal study.
Rajan A; Aati O; Kalluru R; Gamble GD; Horne A; Doyle AJ; McQueen FM; Dalbeth N
Arthritis Res Ther; 2013 Oct; 15(5):R160. PubMed ID: 24286500
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of clinical, laboratory, and imaging findings in patients with a clinical suspicion of gout: a systematic literature review.
Sivera F; Andrès M; Falzon L; van der Heijde DM; Carmona L
J Rheumatol Suppl; 2014 Sep; 92():3-8. PubMed ID: 25180122
[TBL] [Abstract][Full Text] [Related]
10. Changes in Tophus Composition During Urate-Lowering Therapy: A Dual-Energy Computed Tomography Study.
Chen L; Gamble GD; Horne A; Drake J; Doyle AJ; Uhlig T; Stamp LK; Dalbeth N
Arthritis Care Res (Hoboken); 2023 Sep; 75(9):1949-1954. PubMed ID: 36594401
[TBL] [Abstract][Full Text] [Related]
11. Achieving serum urate targets in gout: an audit in a gout-oriented rheumatology practice.
Corbett EJM; Pentony P; McGill NW
Int J Rheum Dis; 2017 Jul; 20(7):894-897. PubMed ID: 28205336
[TBL] [Abstract][Full Text] [Related]
12. Effects of Allopurinol Dose Escalation on Bone Erosion and Urate Volume in Gout: A Dual-Energy Computed Tomography Imaging Study Within a Randomized, Controlled Trial.
Dalbeth N; Billington K; Doyle A; Frampton C; Tan P; Aati O; Allan J; Drake J; Horne A; Stamp LK
Arthritis Rheumatol; 2019 Oct; 71(10):1739-1746. PubMed ID: 31081595
[TBL] [Abstract][Full Text] [Related]
13. Dual-energy computed tomography for gout diagnosis and management.
Dalbeth N; Choi HK
Curr Rheumatol Rep; 2013 Jan; 15(1):301. PubMed ID: 23292817
[TBL] [Abstract][Full Text] [Related]
14. Febuxostat in the treatment of gout patients with low serum uric acid level: 1-year finding of efficacy and safety study.
Shen M; Zhang J; Qian K; Li C; Xu W; Gu B; Wang X; Ren Q; Yang L; Yuan H; Su D; Chen X
Clin Rheumatol; 2018 Nov; 37(11):3107-3113. PubMed ID: 30196323
[TBL] [Abstract][Full Text] [Related]
15. Limitations of the Current Standards of Care for Treating Gout and Crystal Deposition in the Primary Care Setting: A Review.
Keenan RT
Clin Ther; 2017 Feb; 39(2):430-441. PubMed ID: 28089200
[TBL] [Abstract][Full Text] [Related]
16. Assessing tophaceous spinal gout treatment response using dual-energy CT as a point-of-care imaging modality: case report.
Saffarzadeh M; Haydar SMA; Shojania K; Ouellette H; Nicolaou S; Murray N
Skeletal Radiol; 2023 Aug; 52(8):1599-1604. PubMed ID: 36562821
[TBL] [Abstract][Full Text] [Related]
17. [Gout: an overview of available urate lowering therapies].
Richette P
Ann Pharm Fr; 2012 May; 70(3):133-8. PubMed ID: 22655581
[TBL] [Abstract][Full Text] [Related]
18. Ultrasonography and dual-energy computed tomography provide different quantification of urate burden in gout: results from a cross-sectional study.
Pascart T; Grandjean A; Norberciak L; Ducoulombier V; Motte M; Luraschi H; Vandecandelaere M; Godart C; Houvenagel E; Namane N; Budzik JF
Arthritis Res Ther; 2017 Jul; 19(1):171. PubMed ID: 28732526
[TBL] [Abstract][Full Text] [Related]
19. Advances in pharmacotherapy for the treatment of gout.
Robinson PC; Dalbeth N
Expert Opin Pharmacother; 2015 Mar; 16(4):533-46. PubMed ID: 25547991
[TBL] [Abstract][Full Text] [Related]
20. The Tophus Impact Questionnaire (TIQ-20): responsiveness to change during urate-lowering therapy.
Cao C; Gamble G; Horne A; Aati O; Doyle A; Drake J; Stamp LK; Dalbeth N
Rheumatology (Oxford); 2024 May; 63(6):1539-1542. PubMed ID: 37688559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
